➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
McKesson
Baxter
Medtronic
Boehringer Ingelheim
Harvard Business School

Last Updated: August 8, 2020

DrugPatentWatch Database Preview

Acs Dobfar Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for ACS DOBFAR, and what generic and branded alternatives to ACS DOBFAR drugs are available?

ACS DOBFAR has twenty-three approved drugs.



Summary for Acs Dobfar
US Patents:0
Tradenames:14
Ingredients:12
NDAs:23

Drugs and US Patents for Acs Dobfar

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Acs Dobfar CEFOXITIN cefoxitin sodium INJECTABLE;INJECTION 065415-001 May 19, 2010 AP RX No Yes   Start Trial   Start Trial
Acs Dobfar CEFTAZIDIME ceftazidime INJECTABLE;INJECTION 062640-004 Feb 3, 1992 AP RX No No   Start Trial   Start Trial
Acs Dobfar Spa MEROPENEM meropenem INJECTABLE;INJECTION 204139-001 Jun 9, 2016 AP RX No No   Start Trial   Start Trial
Acs Dobfar Spa AMPICILLIN SODIUM ampicillin sodium INJECTABLE;INJECTION 090884-001 Apr 3, 2013 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
Harvard Business School
Johnson and Johnson
Boehringer Ingelheim
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.